Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carol Tan

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
BMJ Health & Care Informatics|August 8, 2024
Perspectives on telemedicine across urban, rural and remote areas in the Philippines during the COVID-19 pandemicNoleen Fabian, Regine Ynez De Mesa, Carol Tan-Lim, et al.
Oncotarget|June 1, 2016
Expression and mutational analysis of c-CBL and its relationship to the MET receptor in head and neck squamous cell carcinomaCleo E Rolle, Yi-Hung Carol Tan, Tanguy Y Seiwert, et al.
International Journal of Oncology|April 3, 2020
Effects of selected deubiquitinating enzyme inhibitors on the proliferation and motility of lung cancer and mesothelioma cell linesTamara Mirzapoiazova, Alexander Pozhitkov, Arin Nam, et al.
International Journal of Surgery (London, England)|December 17, 2025
Clinical efficacy of surgical sealants after pulmonary resection: an individual patient data meta-analysis of randomized controlled trialsMatthew Shiu Hang Wong, Vinci Naruka, Paulo De Sousa, et al.
Cancer Biology & Therapy|October 13, 2018
Inhibiting crosstalk between MET signaling and mitochondrial dynamics and morphology: a novel therapeutic approach for lung cancer and mesotheliomaJiale Wang, Tamara Mirzapoiazova, Yi-Hung Carol Tan, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|June 24, 2017
ANGPTL4 T266M variant is associated with reduced cancer invasivenessZhen Wei Tan, Ziqiang Teo, Carol Tan, et al.
The Lancet. Oncology|July 5, 2011
Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility studyTom Treasure, Loic Lang-Lazdunski, David Waller, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 8, 2009
The Mesothelioma and Radical surgery randomized controlled trial: the Mars feasibility studyTom Treasure, David Waller, Carol Tan, et al.
Oncogenesis|September 6, 2019
EPHA2 mutations with oncogenic characteristics in squamous cell lung cancer and malignant pleural mesotheliomaYi-Hung Carol Tan, Saumya Srivastava, Brian M Won, et al.
Plos One|February 4, 2010
CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinasesYi-Hung Carol Tan, Soundararajan Krishnaswamy, Suvobroto Nandi, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
BMJ Health & Care Informatics|August 8, 2024
Perspectives on telemedicine across urban, rural and remote areas in the Philippines during the COVID-19 pandemicNoleen Fabian, Regine Ynez De Mesa, Carol Tan-Lim, et al.
Oncotarget|June 1, 2016
Expression and mutational analysis of c-CBL and its relationship to the MET receptor in head and neck squamous cell carcinomaCleo E Rolle, Yi-Hung Carol Tan, Tanguy Y Seiwert, et al.
International Journal of Oncology|April 3, 2020
Effects of selected deubiquitinating enzyme inhibitors on the proliferation and motility of lung cancer and mesothelioma cell linesTamara Mirzapoiazova, Alexander Pozhitkov, Arin Nam, et al.
International Journal of Surgery (London, England)|December 17, 2025
Clinical efficacy of surgical sealants after pulmonary resection: an individual patient data meta-analysis of randomized controlled trialsMatthew Shiu Hang Wong, Vinci Naruka, Paulo De Sousa, et al.
Cancer Biology & Therapy|October 13, 2018
Inhibiting crosstalk between MET signaling and mitochondrial dynamics and morphology: a novel therapeutic approach for lung cancer and mesotheliomaJiale Wang, Tamara Mirzapoiazova, Yi-Hung Carol Tan, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|June 24, 2017
ANGPTL4 T266M variant is associated with reduced cancer invasivenessZhen Wei Tan, Ziqiang Teo, Carol Tan, et al.
The Lancet. Oncology|July 5, 2011
Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility studyTom Treasure, Loic Lang-Lazdunski, David Waller, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 8, 2009
The Mesothelioma and Radical surgery randomized controlled trial: the Mars feasibility studyTom Treasure, David Waller, Carol Tan, et al.
Oncogenesis|September 6, 2019
EPHA2 mutations with oncogenic characteristics in squamous cell lung cancer and malignant pleural mesotheliomaYi-Hung Carol Tan, Saumya Srivastava, Brian M Won, et al.
Plos One|February 4, 2010
CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinasesYi-Hung Carol Tan, Soundararajan Krishnaswamy, Suvobroto Nandi, et al.
Pageof 6